RGEN
NASDAQ · Life Sciences Tools & Services
Repligen Corp
$173.49
+5.01 (+2.97%)
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Price Target
Analyst Price Target
-64.2% upside
Low Target
$40.44
Average Target
$62.10
High Target
$74.58
Current Price
$173.49
Current
$173.49
$173.49
Target
$62.10
$62.10
$40.44
$62.10 avg
$74.58
Scenario Analysis
Bear Case
$40.44
-76.7%
Low target
Base Case
$62.10
-64.2%
Avg target
Bull Case
$74.58
+-57.0%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$198.87
-12.8% from high
52-Week Low
$100.99
+71.8% from low
50-Day SMA
$177.35
-2.2% vs SMA
200-Day SMA
$144.99
+19.7% vs SMA
RSI (14)
47.7
Neutral
Target vs 52W High
$62.10
-68.8% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 35 | 86% | $369.21 | -46.9% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -31.3% |
| A | Buy | 29 | 72% | $64.69 | -63.0% |
| IQV | Strong Buy | 27 | 85% | $82.96 | -69.5% |
| WAT | Buy | 30 | 70% | $189.60 | -58.6% |
| MTD | Hold | 19 | 47% | $170.43 | -90.1% |
| ILMN | Buy | 28 | 57% | $169.36 | -20.5% |
| WST | Strong Buy | 22 | 95% | $136.24 | -65.9% |